Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
3 Clin Infect Dis
1 Int J Dermatol
14 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Med Virol
1 J Pediatr
1 J Virol
1 Lancet Infect Dis
1 N Engl J Med
16 PLoS One
1 PLoS Pathog
1 Science
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. DADABHAI S, Chou VB, Pinilla M, Chinula L, et al
    Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
    AIDS. 2024 Mar 4. doi: 10.1097/QAD.0000000000003878.
    PubMed         Abstract available

  2. PATEL D, Beer L, Yuan X, Tie Y, et al
    Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men.
    AIDS. 2024 Feb 8. doi: 10.1097/QAD.0000000000003860.
    PubMed         Abstract available

  3. HIMELHOCH SS, Shuter J
    Authors' response to 'Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment'.
    AIDS. 2024;38:614.

  4. DAUNGSUPAWONG H, Wiwanitkit V
    Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment.
    AIDS. 2024;38:613.

  5. DICKSON S, James K
    Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
    AIDS. 2024;38:610-612.
    PubMed         Abstract available

  6. VANDERVEEN LA, Selzer L, Moldt B, Parvangada A, et al
    HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.
    AIDS. 2024;38:607-610.
    PubMed         Abstract available

  7. LEE D, Capeau J
    Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
    AIDS. 2024;38:603-605.

    Reassessing the emphasis on limited options in antiretroviral treatment.
    AIDS. 2024;38:599-601.

  9. WINSTON A, Price P
    Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?
    AIDS. 2024;38:597-598.

  10. MASCOLO S, Romanelli A
    A new frontier in HIV care: the predictive power of renal biomarkers on heart health.
    AIDS. 2024;38:595-596.

  11. WILSON IB, Cole MB, Lee Y, Shireman TI, et al
    The relationship of age and comorbid conditions to hospital and nursing home days in Medicaid recipients with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003870.
    PubMed         Abstract available

  12. WISEMAN RL, Bigos KL, Dastgheyb RM, Barker PB, et al
    Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in older virally-suppressed people with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003871.
    PubMed         Abstract available

  13. SHIVAKOTI R, Giganti MJ, Lederman MM, Ketchum R, et al
    Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
    AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877.
    PubMed         Abstract available

    AIDS Res Hum Retroviruses

  14. GENG H, Liu B, Liu Y, Chen S, et al
    Identification of the near full-length genome of a novel HIV-1 CRF01_AE/CRF07_BC recombinant in Hebei Province, China.
    AIDS Res Hum Retroviruses. 2024 Feb 26. doi: 10.1089/AID.2023.0119.
    PubMed         Abstract available

    Clin Infect Dis

  15. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.

  16. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    PubMed         Abstract available

  17. SALDANA CS, Burkhardt E, Pennisi A, Oliver K, et al
    Development of a Machine Learning Modelling Tool for Predicting HIV Incidence Using Public Health Data from a County in the Southern United States.
    Clin Infect Dis. 2024 Feb 23:ciae100. doi: 10.1093.
    PubMed         Abstract available

    Int J Dermatol

  18. GORECKA A, Majewski S, Szymanska E, Walecka I, et al
    Skin and mucosal manifestations of immune reconstitution inflammatory syndrome in people living with HIV: a review.
    Int J Dermatol. 2024 Mar 1. doi: 10.1111/ijd.17082.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  19. NGUMBAU NM, Neary J, Wagner AD, Abuna F, et al
    Cofactors of Partner HIV Self-testing and Oral PrEP Acceptance Among Pregnant Women at High Risk of HIV in Kenya.
    J Acquir Immune Defic Syndr. 2024;95:238-245.
    PubMed         Abstract available

  20. VAN HEERDEN JK, Meintjes G, Barr D, Zhao Y, et al
    Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2024;95:260-267.
    PubMed         Abstract available

  21. NABUKALU D, Yiannoutsos CT, Semeere A, Musick BS, et al
    Mortality Among HIV-Infected Adults on Antiretroviral Therapy in Southern Uganda.
    J Acquir Immune Defic Syndr. 2024;95:268-274.
    PubMed         Abstract available

  22. MCCRARY AW, Hung F, Foster MC, Koech M, et al
    Letter to the Editor: Cardiac Dysfunction Among Youth With Perinatal HIV Acquisition and Exposure.
    J Acquir Immune Defic Syndr. 2024;95:e2-e4.

  23. CALZA L, Giglia M, Viale P
    Relationship Between Vitamin D Deficiency and Nonalcoholic Fatty Liver Disease in Patients With HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2024;95:e5-e7.

  24. OPSTEEN S, Fram T, Files JK, Levitan EB, et al
    Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
    J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003399.
    PubMed         Abstract available

  25. LOGAN NZ, Kilmarx PH, Rolle I, Patel HK, et al
    Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018.
    J Acquir Immune Defic Syndr. 2024;95:313-317.
    PubMed         Abstract available

  26. FRANCE AM, Panneer N, Farnham PG, Oster AM, et al
    Simulation of Full HIV Cluster Networks in a Nationally Representative Model Indicates Intervention Opportunities.
    J Acquir Immune Defic Syndr. 2024;95:355-361.
    PubMed         Abstract available

  27. VOLK JE, Leyden WA, Lea AN, Lee C, et al
    Using Electronic Health Records to Improve HIV Preexposure Prophylaxis Care: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2024;95:362-369.
    PubMed         Abstract available

  28. KENNEDY CE, Yeh PT, Verster A, Luhmann N, et al
    Do Peer Navigators Improve Initiation and Retention in HIV/VH/STI Treatment Programs for People From Key Populations? A Systematic Review of Effectiveness, Values and Preferences, and Cost.
    J Acquir Immune Defic Syndr. 2024;95:305-312.
    PubMed         Abstract available

  29. TANAKA T, Oshima K, Kawano K, Tashiro M, et al
    Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999-2021: Trend in Non-AIDS-Defining Cancers Among HIV-1-Infected Individuals.
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003389.
    PubMed         Abstract available

  30. BEN FARHAT J, TiendrebeogoMD T, Malateste K, Poda A, et al
    Effects of the Covid-19 pandemic on ART initiation and access to HIV viral load monitoring in adults living with HIV in West Africa: a regression discontinuity analysis.
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003404.
    PubMed         Abstract available

  31. OBOHO IK, Esber AL, Dear N, Paulin HN, et al
    Advanced HIV Disease in East Africa and Nigeria, in The African Cohort Study (AFRICOS).
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003392.
    PubMed         Abstract available

  32. HANLEY S, Moodley D, Naidoo M, Brummel SS, et al
    J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003387.
    PubMed         Abstract available

    J Infect Dis

  33. XIAO G, Huang W, Zhong Y, Ou M, et al
    Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.
    J Infect Dis. 2024 Feb 27:jiae042. doi: 10.1093.
    PubMed         Abstract available

  34. COLLAZOS J, Asensi V
    Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy.
    J Infect Dis. 2024 Feb 23:jiae095. doi: 10.1093.

    J Med Virol

  35. XIAO J, Luo Y, Li Y, Yao X, et al
    The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
    J Med Virol. 2024;96:e29488.
    PubMed         Abstract available

    J Pediatr

  36. NABUNYA P, Ssewamala FM, Kizito S, Mugisha J, et al
    Preliminary Impact of Group-Based Interventions on Stigma, Mental Health and Treatment Adherence Among Adolescents Living with HIV in Uganda.
    J Pediatr. 2024 Feb 22:113983. doi: 10.1016/j.jpeds.2024.113983.
    PubMed         Abstract available

    J Virol

  37. JOSHI VR, Claiborne DT, Pack ML, Power KA, et al
    A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
    J Virol. 2024 Feb 27:e0172023. doi: 10.1128/jvi.01720.
    PubMed         Abstract available


  38. SAX PE, Thompson MA, Saag MS
    Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.2985.

  39. MARRAZZO J, Tao L, Becker M, Leech AA, et al
    HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
    PubMed         Abstract available

    Lancet Infect Dis

  40. DAS M
    UNICEF report reveals gender gaps persist in HIV.
    Lancet Infect Dis. 2024;24:e159.

    N Engl J Med

  41. RANDOLPH SD, Johnson R
    A Salon-Based Intervention to Improve PrEP Uptake among Black Women.
    N Engl J Med. 2024;390:776-777.

    PLoS One

  42. REHMAN N, Garcia MC, Jones A, Ma J, et al
    Measures of retention in HIV care: A protocol for a mixed methods study.
    PLoS One. 2024;19:e0294824.
    PubMed         Abstract available

  43. MANJATE A, Nilsson C, Axelsson M, Lindroth S, et al
    Laboratory-based evaluation of the 4th-generation AlereTM HIV Combo rapid point-of-care test.
    PLoS One. 2024;19:e0298912.
    PubMed         Abstract available

  44. APPLEBAUM JW, McDonald SE, Widmeyer M, Fabelo HE, et al
    Correction: The impact of pet ownership on healthcare access and utilization among people with HIV.
    PLoS One. 2024;19:e0299559.
    PubMed         Abstract available

  45. TAM MW, Davis VH, Ahluwalia M, Lee RS, et al
    Impact of COVID-19 on access to and delivery of sexual and reproductive healthcare services in countries with universal healthcare systems: A systematic review.
    PLoS One. 2024;19:e0294744.
    PubMed         Abstract available

  46. CHIMWAZA-MANDA W, Kamndaya M, Chipeta EK, Sikweyiya Y, et al
    Sexual health knowledge acquisition processes among very young adolescent girls in rural Malawi: Implications for sexual and reproductive health programs.
    PLoS One. 2024;19:e0276416.
    PubMed         Abstract available

  47. DE KOSTER S, Xavier BB, Lammens C, Perales Selva N, et al
    One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019.
    PLoS One. 2024;19:e0298096.
    PubMed         Abstract available

  48. SHAMU T, Egger M, Mudzviti T, Chimbetete C, et al
    Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.
    PLoS One. 2024;19:e0293162.
    PubMed         Abstract available

  49. TSUI JI, Rossi SL, Cheng DM, Bendiks S, et al
    Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    PLoS One. 2024;19:e0297948.
    PubMed         Abstract available

  50. SABOUR S, Li JF, Lipscomb JT, Santos Tino AP, et al
    Immunocapture of cell surface proteins embedded in HIV envelopes uncovers considerable virion genetic diversity associated with different source cell types.
    PLoS One. 2024;19:e0296891.
    PubMed         Abstract available

  51. CONAN N, Paye CP, Ortuno R, Chijuwa A, et al
    Correction: What gaps remain in the HIV cascade of care? Results of a population-based survey in Nsanje District, Malawi.
    PLoS One. 2024;19:e0299866.
    PubMed         Abstract available

  52. FERREYRA C, Moreto-Planas L, Wagbo Temessadouno F, Alonso B, et al
    Correction: Evaluation of a community-based HIV test and start program in a conflict affected rural area of Yambio County, South Sudan.
    PLoS One. 2024;19:e0299906.
    PubMed         Abstract available

  53. MINJA M, Mbilinyi T, Mkinga B, Philipo EG, et al
    Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.
    PLoS One. 2024;19:e0294940.
    PubMed         Abstract available

  54. CHEGE BM, Mwangi PW, Githinji CG, Bukachi F, et al
    Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome.
    PLoS One. 2024;19:e0298752.
    PubMed         Abstract available

  55. ALMOMANI O, Nnamutete J, Shao Z, Biribawa VM, et al
    Effect of cryopreservation on CD4+ T cell subsets in foreskin tissue.
    PLoS One. 2024;19:e0297884.
    PubMed         Abstract available

  56. ABER JO, Bongomin F, Opio SL, Ochola E, et al
    Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
    PLoS One. 2024;19:e0297617.
    PubMed         Abstract available

    A mathematical model for varicella-zoster and HIV co-dynamic supported by numerical simulations.
    PLoS One. 2024;19:e0299734.
    PubMed         Abstract available

    PLoS Pathog

  58. JOSEPH SB, Abrahams MR, Moeser M, Tyers L, et al
    The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
    PLoS Pathog. 2024;20:e1011974.
    PubMed         Abstract available


  59. LIM SY, Lee J, Osuna CE, Vikhe P, et al
    Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
    Science. 2024 Feb 29:eadf7966. doi: 10.1126/science.adf7966.
    PubMed         Abstract available


  60. MARINDA E, Mathentamo Q, Coulson N, Parker S, et al
    Impact evaluation of a youth led intervention to increase COVID-19 vaccine uptake in Kwazulu-Natal, South Africa.
    Vaccine. 2024 Feb 28:S0264-410X(24)00211-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.